期刊文献+

持续性肾脏替代治疗的药物剂量调整 被引量:6

Drug dosing in continuous renal replacement therapy
原文传递
导出
摘要 持续性肾脏替代治疗(CRRT)时药物剂量的调整由于影响因素众多而较为复杂。适宜的个性化剂量调整,对于保证患者有效治疗和减少药物毒副反应以及抗菌药物耐药产生均十分重要。文章介绍CRRT时影响药物清除的主要因素,以及药物剂量调整的基本原则。 Summary:Drug dosing in patients with acute kidney injury who receiving continuous renal replacement therapy (CRRT) is complicated. Optimal drug dosing lead to effect treatment and failure to correct dose may result in either drug toxicity or treatment failure and development of antibiotic resistance. The major factors affect drug removal and principles for appropri- ate dosage adjustment during CRRT will be dicussed.
作者 姜利
出处 《中国实用内科杂志》 CAS CSCD 北大核心 2012年第6期426-428,共3页 Chinese Journal of Practical Internal Medicine
关键词 持续性肾脏替代治疗 药物剂量 药代动力学 continuous renal replacement therapy drug dosing pharmacokineties
  • 相关文献

参考文献5

  • 1Schetz M.Drug dosing in continuous renal replacement therapy:general rules[].Current Opinion in Critical Care.2007
  • 2Bourquin V,Ponte B,Saudan P,et al.Drugs dosing in inten-sive care unit during continuous renal replacement therapy[].Nephrol Ther.2009
  • 3Ranco C,Bellomo R,Kellum J.Critical care nephrology[]..2009
  • 4Trotman RL,Williamson JC,Shoemaker DM,et al.Antibiotic dosingin critically ill adult patients receiving continuous renal replacementtherapy[].Clinical Infectious Diseases.2005
  • 5Kroh UF.Drug administration in critically ill patients with acute renal failure[].New Horizons.1995

同被引文献120

  • 1曹国颖,孙春华,万冀英,黄义鸣.泰宁在健康人及血液透析尿毒症患者中药代动力学研究[J].中国新药杂志,1994,3(1):48-50. 被引量:3
  • 2杨志福,文爱东,王禾,秦卫军,杨晓剑,窦科峰.替硝唑注射液在肝肾胰联合移植伴连续性肾脏替代治疗患者体内的药代动力学[J].中国临床药理学杂志,2006,22(6):418-421. 被引量:1
  • 3卢玉宝,史忠.连续性肾脏替代治疗(CRRT)的临床治疗进展[J].重庆医学,2007,36(18):1822-1824. 被引量:48
  • 4林善琰.当代肾脏病学[M].上海:上海科学技术教育出版社,2001.837.
  • 5Brunet S, Leblanc M, Geadah D, et al. Diffusive and con- vective solute clearances during continuous renal replace- ment therapy at various dialysate and ultrafiltration flow rates [J]. Am J Kidney Dis, 1999, 34 (3): 486-492.
  • 6Pea F, Viale P, Pavan F, et al. Pharmackkinetic consider- ations for antimicrobial theray in patients receiving re- nal replacement therapy[J]. Cline Pharmacokinet, 2007, 46(12): 997-1038.
  • 7Finkel K W, Podoll A S. Complications of continuous renal replacement therapy[J]. Semin Dial, 2009, 22(2): 155-159.
  • 8Liangos O, Wald R, O'Bell J W, et al. Epidemiology and outcomes of acute renal failure in hospitalized patients: a national survey[J]. Clin J Am Soc Nephrol, 2006, 1(1): 43-51.
  • 9Pannu N, Klarenbach S, Wiebe N, et al. Renal replace- ment therapy in patients with acute renal failure: a sys- tematic review[J]. JAMA, 2008, 299 (7): 793-805.
  • 10Bagshaw S M, Wald R, Barton J, et al. Clinical factorsassociated with initiation of renal replacement therapy in critically ill patients with acute kidney inju:,a prospec- tive multicenter observational study[J]. J Crit Care, 2012, 27(3) : 268-275.

引证文献6

二级引证文献47

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部